Stock 4AB ABBVIE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases AbbVie Inc. BOERSE MUENCHEN

Equities

4AB

US00287Y1091

Market Closed - BOERSE MUENCHEN
Other stock markets
 20:57:15 27/06/2024 BST 		5-day change 1st Jan Change
158 EUR -1.92% Intraday chart for AbbVie Inc. +1.33% +15.33%
06-27 Health Care Stocks Fall With Broad Market -- Health Care Roundup DJ
06-27 Sector Update: Health Care Stocks Slipping Late Afternoon MT

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
AbbVie Acquires Celsius Therapeutics
PR
AbbVie - U.S. Food and Drug Administration Grants Second Approval for EPKINLY to Treat Patients with Relapsed or Refractory Follicular Lymphoma
AQ
Introducing Allē Payment Plans, Powered by Cherry
PR
U.S. Food and Drug Administration Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Patients with Relapsed or Refractory Follicular Lymphoma
PR
AbbVie Provides U.S. Regulatory Update on ABBV-951
AQ
AbbVie Provides U.S. Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa)
PR
AbbVie Declares Quarterly Dividend
AQ
AbbVie Declares Quarterly Dividend
PR
AbbVie Appoints Roxanne S. Austin as Lead Independent Director of the Board of Directors
PR
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio Across Inflammatory Bowel Disease
PR
AbbVie Recommends Shareholders Reject Tutanota's "Mini-Tender" Offer
PR
AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory Bowel Disease
PR
BOTOX® Cosmetic (onabotulinumtoxinA) Reveals 2024 Women Entrepreneur Grant Recipients
PR
AbbVie Launches First-of-its-Kind Contest to Empower People Living with Migraine in their Careers
AQ
AbbVie - SkinMedica Celebrates 25 Years of Empowering Radiant Skin
AQ
AbbVie Announces Positive Topline Results from Phase 2 PICCOLO Trial Evaluating Mirvetuximab Soravtansine (ELAHERE®) for High Folate Receptor-Alpha (FRα) Expressing Platinum-Sensitive Ovarian Cancer
PR
SkinMedica® Celebrates 25 Years of Empowering Radiant Skin
PR
AbbVie Advances Oncology Pipeline With Start of Multiple Myeloma Phase 3 Clinical Trial for Investigational Asset ABBV-383
PR
RINVOQ® (upadacitinib) Now Available for Pediatric Patients Two Years and Older with Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis
PR
Refer Your Friends to Allē, the Loyalty Rewards Program by Allergan Aesthetics, and Earn $50
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABBV Stock
  4. 4AB Stock
  5. News AbbVie Inc.
  6. Press Releases